G

GlycoMimetics
D

GLYC

0.29490
USD
-0.01
(-3.06%)
مغلق
حجم التداول
5,403
الربح لكل سهم
-0
العائد الربحي
-
P/E
-0
حجم السوق
19,025,138
أصول ذات صلة
    ALNY
    ALNY
    -0.480
    (-0.19%)
    250.450 USD
    C
    CRBP
    -0.09000
    (-1.09%)
    8.20000 USD
    G
    GLMD
    0.16000
    (6.25%)
    2.72000 USD
    G
    GLYC
    -0.00930
    (-3.06%)
    0.29490 USD
    P
    PRQR
    -0.02000
    (-0.77%)
    2.57000 USD
    R
    RGNX
    -0.08500
    (-1.15%)
    7.28000 USD
    VRTX
    VRTX
    4.10
    (0.85%)
    484.53 USD
    المزيد
الأخبار المقالات

العنوان: GlycoMimetics

القطاع: Healthcare
الصناعة: Biotechnology
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.